X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4230) 4230
Book Review (688) 688
Publication (267) 267
Newsletter (72) 72
Book Chapter (23) 23
Book / eBook (12) 12
Newspaper Article (12) 12
Conference Proceeding (10) 10
Magazine Article (9) 9
Government Document (6) 6
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3607) 3607
index medicus (3515) 3515
female (2222) 2222
male (2144) 2144
neurofibromatosis (1912) 1912
neurofibromatosis 1 - complications (1720) 1720
adult (1491) 1491
child (1206) 1206
adolescent (1086) 1086
middle aged (982) 982
clinical neurology (787) 787
surgery (779) 779
child, preschool (724) 724
magnetic resonance imaging (651) 651
pediatrics (578) 578
children (567) 567
neurofibromatosis type 1 (559) 559
tumors (552) 552
neurofibromatosis 1 - diagnosis (528) 528
neurofibromatosis 1 - pathology (522) 522
abridged index medicus (460) 460
aged (432) 432
infant (429) 429
treatment outcome (411) 411
neurofibromatosis 1 - genetics (409) 409
diagnosis (377) 377
neurofibromatosis 2 - complications (374) 374
retrospective studies (373) 373
care and treatment (343) 343
medicine & public health (340) 340
oncology (334) 334
nf1 (333) 333
young adult (330) 330
genetics & heredity (326) 326
tomography, x-ray computed (323) 323
research (304) 304
follow-up studies (284) 284
mutation (281) 281
risk factors (267) 267
neurofibromatosis type-1 (266) 266
management (262) 262
neurosciences (259) 259
diagnosis, differential (254) 254
neurofibromatosis 1 (220) 220
type-1 (212) 212
gene (209) 209
disease (207) 207
radiography (205) 205
neurofibromatosis 1 - surgery (202) 202
otorhinolaryngology (201) 201
neurology (199) 199
genetic aspects (197) 197
analysis (193) 193
cancer (193) 193
dermatology (193) 193
pathology (187) 187
case report (182) 182
complications and side effects (180) 180
health aspects (179) 179
neurofibromatosis type 2 (179) 179
vestibular schwannoma (169) 169
animals (168) 168
neurosurgery (163) 163
neurofibromatosis 2 - surgery (162) 162
case studies (159) 159
ophthalmology (159) 159
neurofibroma (157) 157
neurofibromatosis 1 - diagnostic imaging (155) 155
patients (152) 152
phenotype (152) 152
prognosis (152) 152
recklinghausen's disease (149) 149
article (147) 147
neuroma, acoustic - surgery (147) 147
neurofibromatosis 2 - diagnosis (144) 144
gliomas (142) 142
medicine (139) 139
neurofibromatosis 1 - physiopathology (139) 139
neurofibromatosis 2 - pathology (135) 135
congenital, hereditary, and neonatal diseases and abnormalities (132) 132
neurofibromatoses - complications (132) 132
orthopedics (130) 130
radiology, nuclear medicine & medical imaging (130) 130
patient (129) 129
mutations (128) 128
vonrecklinghausen neurofibromatosis (127) 127
genetics (120) 120
medicine, general & internal (120) 120
infant, newborn (119) 119
neoplasms (119) 119
acoustic neuroma (115) 115
medical research (115) 115
nerve sheath tumors (115) 115
development and progression (114) 114
neurofibromin 1 - genetics (111) 111
childhood (110) 110
neurofibromatosis 2 - genetics (110) 110
genes, neurofibromatosis 1 (109) 109
immunohistochemistry (108) 108
schwannoma (108) 108
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4045) 4045
French (127) 127
German (45) 45
Japanese (29) 29
Spanish (29) 29
Polish (16) 16
Italian (10) 10
Russian (10) 10
Chinese (7) 7
Romanian (6) 6
Croatian (5) 5
Portuguese (5) 5
Czech (4) 4
Dutch (4) 4
Hungarian (4) 4
Turkish (3) 3
Bulgarian (2) 2
Korean (2) 2
Swedish (2) 2
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2009, Volume 361, Issue 4, pp. 358 - 367
Journal Article
Journal of Child Neurology, ISSN 0883-0738, 1/2017, Volume 32, Issue 1, pp. 9 - 22
Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder (incidence 1:33 000-40 000) characterized by formation of central nervous system tumors,... 
presentation | treatment | tumors | complications | children | management | neurofibromatosis type 2 | vestibular schwannoma | pediatric | NERVE | BEVACIZUMAB | NATURAL-HISTORY | BILATERAL ACOUSTIC NEUROFIBROMATOSIS | CLINICAL NEUROLOGY | HEARING PRESERVATION | MENINGIOMAS | STEREOTACTIC RADIOSURGERY | TUMOR BURDEN | VESTIBULAR SCHWANNOMA GROWTH | PEDIATRICS | NF2 GENE
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 05/2018, Volume 138, Issue 1, pp. 183 - 190
Immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) or its ligand (PD-L1) have been shown to be effective in treating patients with a variety... 
Tumor infiltrating lymphocytes | Programmed death-ligand 1 | Neurofibromatosis type 1 | Neurofibromatosis type 2 | Meningioma | Neurofibroma | Schwannoma | B7-H1 EXPRESSION | GLIOMA | CANCER | CLINICAL NEUROLOGY | INHIBITION | ONCOLOGY | GROWTH-FACTOR | VESTIBULAR SCHWANNOMAS | PD-L1 ANTIBODIES | CELL | TUMORIGENESIS | Neurofibromatosis 2 - complications | Central Nervous System Neoplasms - metabolism | Meningioma - metabolism | Humans | Middle Aged | Male | Meningioma - complications | Neurilemmoma - pathology | Antigens, CD - metabolism | Young Adult | Meningioma - pathology | B7-H1 Antigen - metabolism | Central Nervous System Neoplasms - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Neurilemmoma - metabolism | Adolescent | Neurofibromatosis 1 - complications | Neurilemmoma - complications | Adult | Female | Central Nervous System Neoplasms - complications | Child | Immunohistochemistry | Lymphocytes | Cell death | Immunotherapy | Neurofibromatosis | Formaldehyde | Cancer | Parkinson's disease | PD-1 protein | Neurodegenerative diseases | Tumor cells | CD8 antigen | Clinical trials | Neurofibromin 2 | CD3 antigen | Paraffin | Recklinghausen's disease | Immunity (cell-mediated) | Immune checkpoint | CD20 antigen | Ligands | Skin | Movement disorders | Apoptosis | Tumors | Index Medicus | meningioma | tumor infiltrating lymphocytes | neurofibromatosis type 1 | neurofibromatosis type 2 | neurofibroma | programmed death-ligand 1 | schwannoma
Journal Article
Journal Article
Journal Article
Developmental Medicine & Child Neurology, ISSN 0012-1622, 12/2018, Volume 60, Issue 12, pp. 1285 - 1288
Journal Article
Journal Article